Radiation beads show promise for liver tumors in small trial
NCT ID NCT04362436
First seen Jan 17, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study tested a treatment called TheraSphere for people with neuroendocrine tumors that have spread to the liver and cannot be removed by surgery. TheraSphere uses tiny radioactive beads delivered directly to the liver to kill cancer cells. The trial included 24 adults who had already tried at least one other treatment, and it looked at safety, tumor shrinkage, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College NHS Trust
London, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.